High-density lipoprotein and mortality before age 90 in male physicians

Circulation: Cardiovascular Quality and Outcomes

Volumn 5, Issue 3, 2012, Pages 381-386

  Rahilly Tierney, Catherine ^a,b   Sesso, Howard D ^b   Gaziano, J Michael ^a,b   Djoussé, Luc ^a,b  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Aging; Epidemiology; Lipoproteins; Prevention

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; FOLLOW UP; HUMAN; LIFESPAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSICIAN; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMORBIDITY; HEALTH SURVEYS; HUMANS; LIFE STYLE; LINEAR MODELS; LIPOPROTEINS, HDL; LONGEVITY; MALE; MIDDLE AGED; PHYSICIANS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; UNITED STATES; UP-REGULATION;

EID: 84864600910     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.111.963850     Document Type: Article

References (32)

1. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977;62:707-714.
2. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986;256:2835-2838.
3. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79:8-15.
4. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, Van-Denburgh M, Willett W, Hennekens CH. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993;329: 1829-1834.
5. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991;325:373-381.
6. Miller NE, Thelle DS, Forde OH, Mjos OD. The Tromsø heart-study: High-density lipoprotein and coronary heart-disease: a prospective casecontrol study. Lancet. 1977;1:965-968.
7. Perova NV, Organov RG, Williams DH, Irving SH, Abernathy JR, Deev AD, Shestov DB, Zhukovsky GS, Davis CE, Tyroler HA. Association of high-density-lipoprotein cholesterol with mortality and other risk factors for major chronic noncommunicable disease in samples of US and Russian men. Ann Epidemiol. 1995;5:179-185.
8. Jacobs DR, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol. 1990;131:32-47.
9. Gordon DJ, Knoke J, Probstfield JL, Superko R, Tyroler HA. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial. Circulation. 1986;74:1217-1225.
10. Stensvold I, Urdal P, Thürmer H, Lund-Larsen PG, Foss OP. Highdensity lipoprotein cholesterol and coronary, cardiovascular, and all cause mortality among middle-aged Norwegian men and women. Eur Heart J. 1992;13:1155-1163.
11. Enger SC, Hjermann I, Foss OP, Helgeland A, Holme I, Leren P, Norum KR. High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study. Artery. 1979;5:1700181.
12. Shaten BJ, Kuller LH, Neaton JD. Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years. MRFIT Research Group. Prev Med. 1991;20:655-659.
13. Multiple Risk Factor Intervention Trial Research Group. Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Prev Med. 1986;15: 254-273.
14. Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, McNamara JR, Kashyap ML, Hershman JM, Wexler LF, Rubins HB. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA. 2001; 285:1585-1591.
15. Campbell AJ, Busby WJ, Roberson MC. Over 80 years and no evidence of coronary heart disease: characteristics of a survivor group. J Am Geriatr Soc. 1993;41:1333-1338.
16. Nikkilä M, Pitkäjärvi T, Koivula T, Heikkinen J. Elevated high-densitylipoprotein cholesterol and normal triglycerides as markers of longevity. Klin Wochenschr. 1991;69:780-785.
17. Nikkilä M, Heikkinen J. High-density lipoprotein cholesterol and longevity. Age Ageing. 1990;19:119-124.
18. Barbagallo CM, Averna MR, Fradà G, Chessari S, Mangiacavallo G, Notarbartolo A. Plasma lipid, apolipoprotein and Lp(a) levels in elderly normolipidemic women: relationships with coronary heart disease and longevity. Gerontology. 1995;41:260-266.
19. Barzilai N, Atzmon G, Schecter C, Schaefer EJ, Cupples AL, Lipton R, Cheng S, Shuldiner AR. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA. 2003;290:2030-2040.
20. Keys A. High density lipoprotein cholesterol and longevity. J Epidemiol Community Health. 1988;42:60-65.
21. Koropatnick TA, Kimbell J, Chen R, Grove JS, Donlon TA, Masaki KH, Rodriguez BL, Willcox BJ, Yano K, Curb JD. A prospective study of high-density lipoprotein cholesterol, cholesterol ester transfer protein gene variants, and healthy aging in very old Japanese-American men. J Gerontol A Biol Sci Med Sci. 2008;63:1235-1240.
22. Rahilly-Tierney CR, Spiro A III, Vokonas P, Gaziano JM. Relation between high-density lipoprotein cholesterol and survival to age 85 years in men (from the VA Normative Aging Study). Am J Cardiol. 2011;107: 1173-1177.
23. Weverling-Rijnsburger AW, Jonkers IJ, van Exel E, Gussekloo J, Westendorp RG. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch Intern Med. 2003;163:1549-1554.
24. The Steering Committee of the Physician's Health Study Research Group: Belanger C, Buring JE, Cook N, Eberlein K, Goldhaber SZ, Gordon D, Hennekens CH, Mayrent SL, Peto R, Rosner B, Stampfer MJ, Stubblefield F, Willett WC, Ryan T, Blaszkowski T, Vargosko A, Cohen LS, Colton T, DeMets D, Deykin D, Friedman L. Final report on the aspirin component of the ongoing Physician's Health Study. N Engl J Med. 1989;10:1425-1505.
25. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, Lamotte R, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of effect of long-term supplementation with beta-carotene on incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996; 334:1145-1149.
26. Sesso HD, Gaziano JM, VanDenBurgh M, Hennekens CH, Glynn RJ, Buring JE. Comparison of baseline characteristics and mortality experience of participants an non-participants in a randomized clinical trial: the Physician's Health Study. Control Clin Trials. 2002;23:686-702.
27. Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension. 2006;47:45-50.
28. Yates LB, Djoussé L, Kurth T, Buring JE, Gaziano JM. Exceptional longevity in men: Modifiable factors associated with survival and function to age 90 years. Arch Intern Med. 2008;168:284-290.
29. Singh IM, Shishehbor MH, Ansell BJ. High-density lipoprotein as a therapeutic target. JAMA. 2007;298:786-798.
30. Ellison RC, Zhang Y, Qureshi MM, Knox S, Arnett DK, Province MA; Investigators of the NHLBI Family Heart Study. Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study. Am Heart J. 2004;147:529-535.
31. Criqui MH. Triglycerides and coronary heart disease revisited (again). Ann Intern Med. 2007;147:425-427.
32. Farwell W, Sesso HD, Buring JE, Gaziano JM. Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction. Am J Cardiol. 2005;96:1129-1134.